Biomarker Testing In Non–Small Cell Lung Cancer - Episode 1

The Role of Biomarker Testing in Metastatic and Resectable NSCLC

, ,

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on biomarker testing in metastatic or resectable non–small cell lung cancer.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: The Role of Biomarker Testing in Metastatic and Resectable NSCLC
    EP. 2: When to Conduct Molecular Testing in NSCLC
    EP. 3: The Utility of Rapid Lung NGS for Biomarker Testing in NSCLC
    EP. 4: The Specificity/Sensitivity of Rapid Lung NGS for Biomarker Testing in NSCLC
    EP. 5: Treatment Planning After Biomarker Testing in NSCLC
    EP. 6: Benefits of In-House Biomarker Testing in NSCLC
    EP. 7: Tissue vs Liquid Biopsies for Biomarker Testing in NSCLC
    EP. 8: How Biomarker Testing Could Continue to Evolve in NSCLC
    x